Document is current

Any future updates will be listed below

Chronic myeloid leukemia incidence, survival and accessibility of tyrosine kinase inhibitors: a report from population-based Lithuanian haematological disease registry 2000–2013

Crossref DOI link: https://doi.org/10.1186/s12885-016-2238-9

Published Online: 2016-03-08

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark